The 89.5% market-implied probability against a new pandemic in 2026 rests on the continued absence of any novel pathogen demonstrating sustained human-to-human transmission at levels that would prompt a World Health Organization declaration. Global surveillance through May 2026 shows only incremental spread of known respiratory viruses, including the minority SARS-CoV-2 BA.3.2 lineage and seasonal influenza subclade K, both producing hospitalization rates comparable to prior years without exceeding epidemic thresholds. A recent localized Andes hantavirus cluster linked to a single cruise ship remains geographically contained, with official assessments confirming negligible risk of broader escalation. Strengthened post-2020 monitoring networks and rapid-response protocols have further compressed the window for undetected emergence before year-end resolution.